Literature DB >> 15265352

Appropriate methods to assess the effectiveness and efficacy of treatments or interventions to control cancer pain.

Claudia Bausewein1, Irene J Higginson.   

Abstract

Pain is common in cancer patients. To ensure optimal pain management efficacy and effectiveness of new drugs and treatments have to be investigated in clinical trials. Efficacy trials such as randomised controlled trials (RCT) are experimental studies and estimate the maximum potential benefit to be derived from an intervention in ideal circumstances and under a controlled environment. RCTs are the only trial design to establish causal effects. A crossover study is a special type of RCT where patients serve as own controls. In efficacy studies the intervention and the control group should be as homogeneous as possible, confounding variables are controlled, bias is reduced, internal validity is high whereas external validity is low. Studies looking at effectiveness assess clinical practice and reflect real life circumstances. They rely high on external validity at the expense of careful controls, the study population is heterogeneous, confounding variables are examined. Cohort studies follow a group or groups of individuals with a common characteristic over a period of time to measure outcomes. Case-control studies start with the outcome and compare the characteristics of two groups of interest, those with the outcome and those without to identify factors which occur more or less often in the poor outcome group. Definition of outcome criteria is crucial both for efficacy and effectiveness studies and is often a primary problem. All clinical studies must use valid and reliable outcome measures.

Entities:  

Mesh:

Year:  2004        PMID: 15265352     DOI: 10.1089/1096621041349572

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  4 in total

1.  Study design, precision, and validity in observational studies.

Authors:  Melissa D A Carlson; R Sean Morrison
Journal:  J Palliat Med       Date:  2009-01       Impact factor: 2.947

2.  Variations in the quality and costs of end-of-life care, preferences and palliative outcomes for cancer patients by place of death: the QUALYCARE study.

Authors:  Barbara Gomes; Paul McCrone; Sue Hall; Jonathan Koffman; Irene J Higginson
Journal:  BMC Cancer       Date:  2010-08-02       Impact factor: 4.430

3.  Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review.

Authors:  Khalaf Ali Al-Jumah; Naseem Akhtar Qureshi
Journal:  Patient Prefer Adherence       Date:  2012-01-31       Impact factor: 2.711

4.  What Patients Can Tell Us: Topic Analysis for Social Media on Breast Cancer.

Authors:  Mike Donald Tapi Nzali; Sandra Bringay; Christian Lavergne; Caroline Mollevi; Thomas Opitz
Journal:  JMIR Med Inform       Date:  2017-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.